Delaying second Pfizer COVID-19 shot boosts immune response in over-80s, study finds

Delaying second Pfizer COVID-19 shot boosts immune response in over-80s, study finds
·3 min read

Extending the gap between doses of the Pfizer–BioNTech COVID-19 vaccine from three to 12 weeks significantly boosts the antibody response in elderly people, according to a new U.K. study.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting